These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26098717)

  • 1. Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder.
    Gałecka E; Talarowska M; Orzechowska A; Górski P; Bieńkiewicz M; Szemraj J
    Acta Biochim Pol; 2015; 62(2):297-302. PubMed ID: 26098717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in the type I deiodinase gene and frontal function in recurrent depressive disorder.
    Gałecka E; Talarowska M; Orzechowska A; Górski P; Szemraj J
    Adv Med Sci; 2016 Sep; 61(2):198-202. PubMed ID: 26866568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder in a subset of Chinese population.
    He B; Li J; Wang G; Ju W; Lu Y; Shi Y; He L; Zhong N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):986-90. PubMed ID: 19427350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment.
    Luo M; Zhou XH; Zou T; Keyim K; Dong LM
    Genet Mol Res; 2015 May; 14(2):5407-16. PubMed ID: 26125736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.
    Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
    J Affect Disord; 2011 Mar; 129(1-3):175-82. PubMed ID: 20888049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms of iodothyronine deiodinases (DIO1, DIO3) genes are not associated with recurrent depressive disorder.
    Gałecka E; Talarowska M; Maes M; Su KP; Górski P; Szemraj J
    Pharmacol Rep; 2016 Oct; 68(5):913-7. PubMed ID: 27351946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters.
    Peeters RP; van den Beld AW; Attalki H; Toor Hv; de Rijke YB; Kuiper GG; Lamberts SW; Janssen JA; Uitterlinden AG; Visser TJ
    Am J Physiol Endocrinol Metab; 2005 Jul; 289(1):E75-81. PubMed ID: 15727947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine.
    Cooper-Kazaz R; van der Deure WM; Medici M; Visser TJ; Alkelai A; Glaser B; Peeters RP; Lerer B
    J Affect Disord; 2009 Jul; 116(1-2):113-6. PubMed ID: 19064291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development.
    Gałecki P; Gałecka E; Maes M; Orzechowska A; Berent D; Talarowska M; Bobińska K; Lewiński A; Bieńkiewicz M; Szemraj J
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():117-24. PubMed ID: 23673188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe.
    de Jong FJ; Peeters RP; den Heijer T; van der Deure WM; Hofman A; Uitterlinden AG; Visser TJ; Breteler MM
    J Clin Endocrinol Metab; 2007 Feb; 92(2):636-40. PubMed ID: 17105838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between DIO polymorphism and aerobic endurance].
    Zhou WT; Hu Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Feb; 35(2):183-188. PubMed ID: 31250614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Thr92Ala polymorphism in the type 2 deiodinase gene is linked to depression in patients with COVID-19 after hospital discharge.
    Beltrão DCA; Beltrão FEL; Carvalhal G; Beltrão FLL; Brito ADS; Silva HDS; Teixeira HMP; Rodrigues JL; de Figueiredo CAV; Costa RDS; Pordeus LCM; Vieira GC; Ramos HE
    Front Endocrinol (Lausanne); 2024; 15():1366500. PubMed ID: 38911040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression levels of interferon-ɣ and type 2 deiodinase in patients diagnosed with recurrent depressive disorders.
    Gałecka E; Talarowska M; Maes M; Su KP; Górski P; Kumor-Kisielewska A; Szemraj J
    Pharmacol Rep; 2018 Feb; 70(1):133-138. PubMed ID: 29367100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of SNPs at 18 positional candidate genes, located within the GD-1 locus on chromosome 14q23-q32, for susceptibility to Graves' disease: a TDT study.
    Chistiakov DA; Savost'anov KV; Turakulov RI
    Mol Genet Metab; 2004 Nov; 83(3):264-70. PubMed ID: 15542398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of C3435T Polymorphism of the ABCB1 Gene on Genetic Susceptibility to Depression and Treatment Response in Polish Population - Preliminary Report.
    Jeleń AM; Sałagacka A; Żebrowska MK; Mirowski M; Talarowska M; Gałecki P; Balcerczak EI
    Int J Med Sci; 2015; 12(12):974-9. PubMed ID: 26664259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland.
    Gałecka E; Szemraj J; Bieńkiewicz M; Majsterek I; Przybyłowska-Sygut K; Gałecki P; Lewiński A
    Mol Biol Rep; 2013 Feb; 40(2):1693-9. PubMed ID: 23073785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rs225017 polymorphism in the 3'UTR of the human DIO2 gene is associated with increased insulin resistance.
    Leiria LB; Dora JM; Wajner SM; Estivalet AA; Crispim D; Maia AL
    PLoS One; 2014; 9(8):e103960. PubMed ID: 25105294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DIO2 as a new susceptibility locus for symptomatic osteoarthritis.
    Meulenbelt I; Min JL; Bos S; Riyazi N; Houwing-Duistermaat JJ; van der Wijk HJ; Kroon HM; Nakajima M; Ikegawa S; Uitterlinden AG; van Meurs JB; van der Deure WM; Visser TJ; Seymour AB; Lakenberg N; van der Breggen R; Kremer D; van Duijn CM; Kloppenburg M; Loughlin J; Slagboom PE
    Hum Mol Genet; 2008 Jun; 17(12):1867-75. PubMed ID: 18334578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder.
    Gałecki P; Maes M; Florkowski A; Lewiński A; Gałecka E; Bieńkiewicz M; Szemraj J
    Neurosci Lett; 2010 Dec; 486(3):184-7. PubMed ID: 20869428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder.
    Gałecki P; Szemraj J; Bartosz G; Bieńkiewicz M; Gałecka E; Florkowski A; Lewiński A; Karbownik-Lewińska M
    J Pineal Res; 2010 May; 48(4):311-7. PubMed ID: 20433639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.